Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Diabetes
diabetes.co.uk > news > 2026 > sep > new-glp-1-review-shows-weight-loss-drugs-are-getting-stronger.html

New GLP-1 review shows weight loss drugs are getting stronger

1+ week, 5+ day ago   (293+ words) GLP-1 medicines are no longer just diabetes drugs. They are now reshaping obesity treatment, and a new review shows how quickly the field is moving. Researchers reviewed 38 randomised controlled trials involving more than 25,000 adults with overweight or obesity who did…...

Diabetes
diabetes.co.uk > news > 2026 > sep > retatrutide-fakes-are-flooding-the-uk-black-market-and-it-is-not-worth-the-risk.html

Retatrutide fakes are flooding the UK black market and it is not worth the risk

6+ day, 20+ hour ago   (701+ words) Retatrutide has not yet been approved for human use in the UK. That has not stopped fake versions being sold through social media, gyms, beauty salons and unregulated online suppliers. This is the dangerous side of the weight-loss drug boom....

Diabetes
diabetes.co.uk > news > 2026 > sep > glp-1-medicines-not-linked-to-major-mental-health-harm-in-new-review.html

GLP-1 medicines not linked to major mental health harm in new review

1+ week, 5+ day ago   (288+ words) Concerns about GLP-1 medicines and mental health have been circulating for several years. A new review suggests the strongest evidence does not support a link with major psychiatric harm. They looked at claims that GLP-1 receptor agonists may increase suicidal…...